AI uncovers a novel CBLB inhibitor for hard-to-treat tumors
Insilico Medicine - 01-Dec-2025ISM3830 boosts immune attack and delivers strong preclinical tumour control
Join the club for FREE to access the whole archive and other member benefits.
ISM3830 boosts immune attack and delivers strong preclinical tumour control
VCPI will generate massive high-quality pharmacology data to standardize virtual cell models
AI-driven experiments will map how molecules penetrate tough Gram-negative bacteria
Ageing clocks reveal 27% more drug targets, speeding multi-disease therapy
Insilico’s AI cut drug discovery to 18 months, spurring Lilly’s investment
Click on resource name for more details.
The Pauling Principle podcast- Andrew White’s team at Future House is building an AI scientist
Podcast from Beyond Biotech-Elise de Reus explores how their platform is putting tech into biotech
Podcast from Beyond Biotech- LabGenius: Cutting through AI hype in drug development
Podcast from Beyond Biotech- Alex Telford on AI, digital twins, and biotech’s biggest questions
Levity Podcast Episode- Alex Zhavoronkov is advancing pharma-focused AI superintelligence
No blog posts found!